<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="22%"></col>
<col width="40%"></col>
<col width="39%"></col>
<tbody>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Concomitant Drug Name or Drug Class</content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Clinical Rationale</content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Clinical Recommendation</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>Strong CYP3A4 Inhibitors (e.g., ketoconazole) or strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine) </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>The concomitant use of oral aripiprazole with strong CYP 3A4 or CYP2D6 inhibitors increased the exposure of aripiprazole<br/>
<content stylecode="italics">[see <linkhtml href="#S12.3">CLINICAL PHARMACOLOGY (12.3)</linkhtml>].</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>With concomitant use of ABILIFY MAINTENA with a strong CYP3A4 inhibitor or CYP2D6 inhibitor for more than 14 days, reduce the ABILIFY MAINTENA dosage <br/>
<content stylecode="italics">[see <linkhtml href="#S2.3">DOSAGE AND ADMINISTRATION (2.3)]. </linkhtml>
</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>Strong CYP3A4 Inducers (e.g., carbamazepine)</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>The concomitant use of oral aripiprazole and carbamazepine decreased the exposure of aripiprazole <content stylecode="italics">[see <linkhtml href="#S12.3">CLINICAL PHARMACOLOGY (12.3)</linkhtml>].</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>Avoid use of ABILIFY MAINTENA in combination with carbamazepine and other inducers of CYP3A4 for greater than 14Â days <content stylecode="italics">[see <linkhtml href="#S2.3">DOSAGE AND ADMINISTRATION (2.3)</linkhtml>]</content>.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>Antihypertensive Drugs</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>Due to its alpha adrenergic antagonism, aripiprazole has the potential to enhance the effect of certain antihypertensive agents.</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>Monitor blood pressure and adjust dose accordingly <content stylecode="italics">[see</content>
<content stylecode="italics">
<linkhtml href="#S5.6">WARNINGS AND PRECAUTIONS (5.7)</linkhtml>].  </content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule " valign="middle">
<paragraph>Benzodiazepines (e.g., lorazepam)</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule " valign="middle">
<paragraph>The intensity of sedation was greater with the combination of oral aripiprazole and lorazepam as compared to that observed with aripiprazole alone. The orthostatic hypotension observed was greater with the combination as compared to that observed with lorazepam alone <content stylecode="italics">[see  <linkhtml href="#_RefS5.7">WARNINGS AND PRECAUTIONS  (5.7)</linkhtml>].</content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule " valign="middle">
<paragraph>Monitor sedation and blood pressure. Adjust dose accordingly.</paragraph>
</td>
</tr>
</tbody>
</table>